TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event

Risk & Weakness

Downward Momentum

53 Findings · last calculated September 18, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 53 hits from US

Methodology & criteria

Weak 3-month RS (≤ 10) and falling today — negative momentum.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(16)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Momentum
The driving force behind a price trend: stocks that have recently risen sharply statistically tend to keep rising more often than not. Momentum strategies therefore buy strength - not perceived bargains.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Relative Strength (RS Rating)
How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Downward Momentum
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
ZURA Zura Bio Limited 08/13 -21 % ⚠ Wildest 10% 92 % Stage 1 D 37 3 of 9 0.4 $ Biotechnology Healthcare 4.60 $ -17.8 % +25.1 % +140.5 % −39.0 % +267.3 % 90 42 9.7 % 8.0 % -0.03 0.0 -2.3 0.0 % -41.0 % -31.2 % 3 0.0 % 0.0 % 23.1 78.6 % 15.5 % 4.6 (7)
RHLD Resolute Holdings Management, Inc. 08/06 ⚠ Wildest 10% 104 % Stage 1 D 44 3 of 9 1.0 $ Specialty Business Services Industrials 117.90 $ -40.0 % -36.8 % +76.3 % −47.1 % 87 50 6.6 % 6.5 % 17.0 0.0 0.9 32.0 12.0 13.8 43.0 % 4.2 % 1.2 % 2.6 % 72.19 +9.9 % 8 0.0 % 0.0 % 3.7 47.7 % 7.9 %
MAZE Maze Therapeutics, Inc. 08/11 67 % Stage 4 D 30 3 of 9 1.3 $ Biotechnology Healthcare 23.40 $ -36.3 % -31.1 % -0.3 % −49.6 % +153.2 % 41 50 5.1 % 5.1 % 8.5 64.8 3.7 6.1 100.0 % 0.0 % -38.7 % -21.8 % 0.18 -100.0 % 3 0.0 % 0.0 % 7.5 95.6 % 12.0 % 4.8 (4)
OIS Oil States International Inc 07/30 +5 % 54 % Stage 1 D 38 4 of 9 0.5 $ Oil & Gas Equipment & Services Energy 8.40 $ +16.7 % +16.1 % +47.1 % −45.2 % +27.9 % 40 12 3.5 % 3.6 % 1.12 19.2 0.8 0.9 9.0 1.01 6.3 21.8 % -16.8 % -17.8 % 1.7 % 0.13 -3.4 % 4 0.0 % 0.0 % 6.9 92.0 % 4.2 % 4.0 (4)
BTU Peabody Energy Corp 07/30 +7 % 58 % Stage 4 D 38 4 of 9 3.3 $ Thermal Coal Energy 27.20 $ -17.9 % -24.0 % +29.5 % −42.4 % +13.1 % 37 11 4.3 % 5.5 % 0.33 24.7 0.8 0.9 17.2 13.0 -4.7 % 10.4 % -4.6 % -2.9 % -1.5 % 0.12 61.2 % -8.9 % 4 1.1 % 27.5 % 6.4 101.0 % 13.8 % 4.3 (6)
LRMR Larimar Therapeutics Inc 08/13 +4 % ⚠ Wildest 10% 103 % Stage 4 D 37 2 of 9 0.4 $ Biotechnology Healthcare 3.80 $ -3.4 % -19.4 % -6.9 % −45.5 % +266.7 % 32 42 9.0 % 7.4 % 0.75 0.0 -4.1 0.0 % -109.8 % -71.0 % 3 0.0 % 0.0 % -1.1 85.7 % 20.4 % 4.9 (11)
WLK Westlake Chemical Corporation 08/04 -9 % 44 % Stage 1 D 34 2 of 9 9.0 $ Specialty Chemicals Basic Materials 70.60 $ +4.6 % +2.5 % -16.7 % −38.4 % +31.5 % 23 11 3.5 % 3.1 % 0.63 15.0 0.8 1.70 156.3 -5.8 % 10.2 % -10.9 % -16.0 % 0.4 % 43.4 % -8.0 % 4 3.0 % 3.0 % 6.0 35.2 % 17.4 % 3.8 (14)
ODYS Odysight.ai Inc. 08/12 -18 % 73 % Stage 1 D 35 2 of 9 0.1 $ Scientific & Technical Instruments Technology 3.40 $ +21.5 % +27.9 % -15.7 % −64.3 % +93.4 % 19 42 6.2 % 7.5 % -0.50 0.0 60.0 2.5 -2.0 34.9 % 0.0 % -63.1 % -41.0 % 0.03 -23.9 % 5 0.0 % 0.0 % 1.1 25.8 % 0.3 %
PATK Patrick Industries Inc 07/30 +29 % 37 % Stage 4 C 51 4 of 9 2.3 $ Recreational Vehicles Consumer Cyclical 69.90 $ -18.9 % -16.5 % -32.9 % −37.6 % +54.5 % 17 31 4.0 % 3.7 % 1.09 18.6 13.6 0.6 2.0 17.8 3.46 8.9 6.5 % 23.1 % 3.7 % 11.7 % 5.3 % 1.35 36.9 % +6.3 % 1 2.7 % 44.3 % 6.7 112.4 % 19.3 % 4.0 (9)
USGO U.S. GoldMining Inc. 08/13 -12 % 69 % Stage 4 E 24 4 of 9 0.1 $ Other Industrial Metals & Mining Basic Materials 7.70 $ -6.1 % -12.3 % -18.0 % −55.8 % +382.7 % 16 42 6.0 % 6.8 % 1.88 0.0 16.8 -7.1 0.0 % -159.5 % -101.0 % 0.01 3 0.0 % 0.0 % -2.6 9.0 % 7.8 % 4.0 (1)
CLB Core Laboratories NV 07/22 -16 % 55 % Stage 4 C 47 4 of 9 0.5 $ Oil & Gas Equipment & Services Energy 11.40 $ -27.3 % -33.9 % -8.4 % −46.4 % +23.3 % 15 20 4.7 % 4.6 % 1.08 18.4 19.8 1.0 1.9 44.1 1.67 11.4 19.5 % 4.7 % 11.1 % 4.5 % 0.62 +0.5 % 5 0.3 % 6.7 % 6.9 113.7 % 21.4 % 3.0 (5)
NOG Northern Oil & Gas Inc 07/30 -10 % 46 % Stage 1 C 50 3 of 9 2.8 $ Oil & Gas E&P Energy 25.20 $ -8.2 % -14.2 % +5.0 % −36.9 % +19.5 % 12 21 4.1 % 3.9 % 0.75 5.4 1.1 1.5 7.35 17.3 -73.6 % 75.4 % -24.2 % -29.8 % 4.6 % 1.43 32.4 % -3.2 % 3 6.6 % 48.3 % 2.4 107.0 % 24.2 % 3.8 (9)
PRIM Primoris Services Corporation 08/03 +67 % ⚠ Wildest 10% 94 % Stage 4 C 47 3 of 9 5.3 $ Engineering & Construction Industrials 76.60 $ -31.5 % -24.8 % -37.1 % −53.6 % +53.8 % 11 12 10.3 % 8.2 % 1.44 16.8 13.1 0.7 2.4 60.4 1.22 16.4 1.8 % 8.6 % 1.9 % 15.9 % 3.0 % 1.12 40.0 % +19.0 % 8 0.4 % 9.9 % 6.3 105.1 % 12.9 % 4.6 (11)
OFIX Orthofix Medical Inc 08/04 -17 % 47 % Stage 4 C 49 4 of 9 0.3 $ Medical Devices Healthcare 8.60 $ -40.0 % -36.1 % -42.2 % −45.2 % +42.9 % 11 42 4.9 % 5.6 % 0.65 500.0 0.4 48.83 26.0 71.3 % -7.4 % -13.4 % -2.7 % +2.9 % 3 0.0 % 0.0 % 4.7 92.1 % 6.6 % 4.0 (5)
DTI Drilling Tools International Corp. 08/12 -16 % 77 % Stage 1 D 33 3 of 9 0.1 $ Oil & Gas Equipment & Services Energy 2.50 $ -9.8 % -31.1 % -3.5 % −58.7 % +76.0 % 11 6 6.3 % 5.1 % -0.61 8.3 0.6 0.7 0.93 5.7 72.5 % -2.0 % -3.0 % 0.5 % 0.64 +3.4 % 2 0.0 % 0.0 % 5.5 19.8 % 1.5 % 3.0 (1)
MBOT Microbot Medical Inc 08/11 -24 % 68 % Stage 4 C 47 4 of 9 0.1 $ Medical Instruments & Supplies Healthcare 1.40 $ -9.0 % -14.2 % -57.2 % −62.1 % +376.2 % 11 42 4.5 % 5.8 % 1.03 31.7 306.7 1.3 0.70 -0.9 -185.3 % 0.0 % -27.6 % -21.7 % 0.01 -100.0 % 3 0.0 % 0.0 % 23.3 21.8 % 10.8 % 4.0 (1)
SAMG Silvercrest Asset Management Group Inc 07/30 -14 % 34 % Stage 4 D 42 3 of 9 0.1 $ Asset Management Financial Services 9.60 $ -30.4 % -29.6 % -36.1 % −39.3 % +85.6 % 11 4 6.2 % 4.1 % 0.67 32.4 11.1 0.6 1.7 8.9 0.98 12.1 29.9 % 0.7 % 4.7 % 1.1 % 0.61 +1.4 % 5 8.7 % 142.4 % 6.1 68.6 % 3.0 % 5.0 (1)
ULH Universal Logistics Holdings Inc 07/23 -15 % ⚠ Wildest 10% 88 % Stage 4 D 41 3 of 9 0.5 $ Trucking Industrials 18.00 $ -2.4 % -2.8 % -22.3 % −50.5 % -15.3 % 10 6 6.3 % 6.6 % 0.76 11.2 0.3 0.9 13.1 3.73 5.5 19.1 % -6.0 % -18.5 % 1.2 % 1.73 -15.6 % 4 2.2 % 4.2 % 4.6 28.6 % 13.3 % 3.0 (1)
BRFH Barfresh Food Group Inc 08/12 +18 % 68 % Stage 4 C 52 3 of 9 0.0 $ Beverages - Non-Alcoholic Consumer Defensive 1.10 $ -31.7 % -26.1 % -61.9 % −67.1 % +263.6 % 10 42 6.6 % 5.8 % 0.73 13.9 0.9 11.0 -5.6 13.0 % -17.9 % -116.1 % -24.7 % 4.69 +32.6 % 4 0.0 % 0.0 % -12.6 22.3 % 0.4 % 4.5 (2)
G Genpact Limited 08/06 -6 % 39 % Stage 4 C 54 2 of 9 5.9 $ Information Technology Services Technology 35.00 $ -38.9 % -41.5 % -14.7 % −43.1 % +20.5 % 9 64 4.4 % 4.2 % 0.59 10.9 18.3 1.1 2.4 10.4 1.16 7.4 15.4 % 36.5 % 11.1 % 23.1 % 9.2 % 2.49 44.1 % +6.6 % 5 2.1 % 19.3 % 7.0 109.3 % 7.8 % 3.9 (11)
CVRX CVRx Inc 08/03 -21 % ⚠ Wildest 10% 121 % Stage 4 C 45 3 of 9 0.1 $ Medical Devices Healthcare 3.00 $ -27.5 % -22.7 % -55.8 % −53.5 % +52.8 % 9 42 6.8 % 7.0 % 0.76 0.0 1.4 -1.3 86.9 % -84.9 % -107.0 % -28.7 % +10.5 % 6 0.0 % 0.0 % -13.5 63.6 % 10.3 % 4.6 (7)
JRVR James River Group Holdings Ltd 08/03 -26 % 50 % Stage 4 D 32 1 of 9 0.2 $ Insurance - Specialty Financial Services 3.80 $ -36.5 % -30.1 % -24.8 % −44.0 % +21.2 % 8 13 4.7 % 4.3 % -0.21 9.1 6.0 0.3 0.3 0.0 35.4 % 4.7 % 4.7 % 0.6 % 0.51 -2.8 % 3 1.0 % 4.3 % 2.7 81.3 % 4.4 % 4.3 (4)
BDTX Black Diamond Therapeutics Inc 08/06 -25 % ⚠ Wildest 10% 87 % Stage 4 E 20 1 of 9 0.1 $ Biotechnology Healthcare 1.90 $ -33.7 % -34.5 % -38.9 % −65.6 % +426.3 % 8 42 8.1 % 9.6 % 3.31 8.3 1.1 2.6 0.0 % -35.2 % -19.1 % 0.17 4 0.0 % 0.0 % -1.1 78.6 % 15.3 % 4.8 (4)
CNXC Concentrix Corporation -23 % 69 % Stage 4 D 35 4 of 9 1.7 $ Information Technology Services Technology 28.30 $ -40.1 % -38.1 % -46.5 % −63.8 % +28.1 % 6 9 7.0 % 6.3 % 0.46 2.6 0.2 3.6 0.37 11.1 34.5 % -13.2 % -38.9 % 3.4 % +2.2 % 5 4.9 % 13.5 % 3.3 105.3 % 18.1 % 4.0 (6)
ABR Arbor Realty Trust 08/07 -15 % 44 % Stage 4 C 46 3 of 9 0.9 $ REIT - Mortgage Real Estate 4.50 $ -29.9 % -28.1 % -56.6 % −59.3 % +30.6 % 6 2 3.6 % 4.3 % 1.12 11.5 11.7 0.4 3.2 1.65 0.0 79.2 % 11.6 % 4.1 % 0.4 % 3.96 +93.0 % 8 20.8 % 136.2 % 2.7 61.8 % 0.0 % 2.8 (4)
FMC FMC Corporation 07/29 -29 % ⚠ Wildest 10% 87 % Stage 4 D 27 1 of 9 1.3 $ Agricultural Inputs Basic Materials 10.20 $ -20.2 % -12.5 % -71.7 % −74.7 % +33.1 % 5 7 6.0 % 5.7 % 0.42 6.4 0.4 0.7 6.4 0.46 10.8 -0.5 % 31.9 % -84.8 % -78.4 % 0.6 % 2.56 19.3 % -18.3 % 2 2.8 % 15.1 % 5.3 95.7 % 31.2 % 3.6 (20)
SOC Sable Offshore Corp. 08/11 -4 % ⚠ Wildest 10% 163 % Stage 1 D 44 3 of 9 0.8 $ Oil & Gas Drilling Neutral Energy 4.40 $ -43.6 % -35.9 % -82.2 % −82.9 % +121.6 % 5 42 8.8 % 9.1 % -0.16 5.4 6.1 1.8 -130.8 -9,343.4 % -128.2 % 0.0 % -141.7 % -14.0 % 1.73 30.7 % 0.0 % 0.0 % -1.8 79.5 % 30.3 % 4.8 (5)
UPWK Upwork Inc 08/05 -3 % 62 % Stage 4 C 53 4 of 9 1.0 $ Internet Content & Information Communication Services 8.50 $ -58.6 % -60.4 % -53.1 % −65.6 % +16.2 % 5 26 4.3 % 4.7 % 1.01 10.7 5.8 1.3 4.1 5.3 0.98 5.5 77.2 % 12.9 % 18.8 % 6.6 % 0.67 +2.4 % 6 0.0 % 0.0 % 6.4 98.9 % 23.7 % 3.7 (11)
AKBA Akebia Therapeutics, Inc. 08/06 +3 % 83 % Stage 4 D 29 1 of 9 0.2 $ Drug Manufacturers - Specialty & Generic Healthcare 0.8955 $ -31.7 % -34.7 % -68.0 % −74.5 % +326.7 % 5 42 7.0 % 7.4 % 0.19 28.7 1.1 9.3 5.9 64.4 81.4 % -13.5 % -79.0 % -1.1 % 0.46 +47.5 % 5 0.0 % 0.0 % -10.8 42.1 % 8.4 % 4.8 (4)
CRDF Cardiff Oncology Inc 08/04 -5 % ⚠ Wildest 10% 92 % Stage 4 D 35 3 of 9 0.1 $ Biotechnology Healthcare 1.30 $ -55.5 % -60.1 % -35.3 % −73.5 % +277.4 % 5 42 10.3 % 10.0 % 1.46 0.0 247.5 2.6 -3.7 -6,854.5 % 0.0 % -84.8 % -46.7 % 0.02 -13.2 % 5 0.0 % 0.0 % -25.3 32.8 % 15.3 % 4.7 (7)
NEGG Newegg Commerce Inc 07/28 -9 % ⚠ Wildest 10% 101 % Stage 4 D 32 3 of 9 0.3 $ Internet Retail Consumer Cyclical 12.90 $ -67.9 % -69.0 % -72.4 % −88.0 % -77.4 % 5 17 6.8 % 9.8 % 3.56 51.9 0.0 1.7 14.5 12.5 % 0.7 % 3.9 % 1.1 % 0.33 +16.9 % 4 0.0 % 0.0 % 4.7 0.6 % 26.9 %
TNXP Tonix Pharmaceuticals Holding Corp 08/10 -33 % 70 % Stage 4 C 51 3 of 9 0.2 $ Biotechnology Healthcare 11.40 $ -23.4 % -24.1 % -58.8 % −82.9 % +277.1 % 5 42 7.9 % 8.3 % 1.75 0.0 6.2 0.9 0.9 83.8 % 0.0 % -72.3 % -46.8 % 0.01 +29.9 % 4 0.0 % 0.0 % 0.4 45.6 % 18.1 % 5.0 (2)
SHAK Shake Shack Inc 07/30 -9 % 58 % Stage 4 C 53 4 of 9 2.5 $ Restaurants Consumer Cyclical 55.90 $ -33.3 % -35.6 % -43.6 % −61.8 % +48.1 % 4 70 4.5 % 5.1 % 1.66 58.9 39.4 1.6 4.4 252.1 2.55 16.4 -0.5 % 40.4 % 2.6 % 8.5 % 2.0 % 1.78 27.4 % +15.4 % 6 0.0 % 0.0 % 4.6 107.8 % 10.9 % 3.7 (24)
UPB Upstream Bio, Inc. 08/05 ⚠ Wildest 10% 100 % Stage 4 D 39 3 of 9 0.3 $ Biotechnology Healthcare 5.30 $ -76.7 % -77.1 % -66.9 % −81.1 % +466.2 % 4 50 5.8 % 6.4 % 0.0 91.3 1.0 0.0 100.0 % 0.0 % -41.8 % -30.3 % 0.00 +20.4 % 5 0.0 % 0.0 % 25.0 89.5 % 11.5 % 4.5 (4)
GOGO Gogo Inc 08/06 -27 % 69 % Stage 4 C 46 4 of 9 0.3 $ Telecom Services Communication Services 2.50 $ -28.3 % -33.0 % -72.0 % −81.3 % +226.9 % 4 56 5.8 % 6.7 % 1.03 27.2 4.2 0.4 3.1 7.6 41.6 % -0.1 % 13.9 % 5.6 % 7.65 +104.7 % 5 0.0 % 0.0 % 1.8 72.3 % 16.4 % 3.8 (4)
DCGO DocGo Inc 08/06 -32 % ⚠ Wildest 10% 90 % Stage 4 D 27 3 of 9 0.0 $ Medical Care Facilities Healthcare 0.3731 $ -42.3 % -43.6 % -74.8 % −74.2 % +392.7 % 4 58 10.1 % 8.5 % 0.94 60.2 0.1 0.3 5.6 30.1 % -65.3 % -97.8 % -19.8 % 0.22 -47.7 % 4 0.0 % 0.0 % -2.0 43.3 % 2.4 % 4.0 (7)
ATYR aTyr Pharma, Inc. 08/06 -25 % ⚠ Wildest 10% 113 % Stage 4 D 37 1 of 9 0.0 $ Biotechnology Healthcare 0.3765 $ -31.4 % -23.3 % -63.3 % −92.3 % +643.8 % 4 42 10.5 % 9.9 % 0.53 0.0 0.6 -0.8 -24,682.1 % 0.0 % -105.6 % -46.6 % 0.20 -19.2 % 2 0.0 % 0.0 % -20.5 48.6 % 10.9 % 4.6 (11)
VERI Veritone Inc 08/06 -22 % ⚠ Wildest 10% 111 % Stage 4 D 34 4 of 9 0.1 $ Software - Infrastructure Sells AI Technology 1.10 $ -69.5 % -74.5 % -73.7 % −86.4 % +388.6 % 4 91 7.7 % 7.5 % 2.27 666.7 1.2 2.0 -7.6 66.2 % -117.5 % -349.4 % -29.0 % 0.93 -0.5 % 2 0.0 % 0.0 % -14.4 25.7 % 17.6 % 4.3 (4)
FULC Fulcrum Therapeutics Inc 08/04 +8 % ⚠ Wildest 10% 106 % Stage 4 D 38 4 of 9 0.2 $ Biotechnology Healthcare 3.80 $ -66.0 % -68.9 % -48.5 % −77.1 % -7.9 % 3 42 6.4 % 8.1 % 2.59 0.0 0.8 -3.1 0.0 % -27.1 % -19.6 % 0.02 -100.0 % 3 0.0 % 0.0 % 28.2 116.3 % 9.3 % 3.6 (7)
ACTU Actuate Therapeutics, Inc. 08/13 ⚠ Wildest 10% 101 % Stage 4 D 40 4 of 9 0.0 $ Biotechnology Healthcare 0.9952 $ -68.5 % -75.9 % -85.6 % −78.7 % +1,071.4 % 3 42 10.3 % 12.5 % 0.96 0.0 6.7 0.0 0.0 % -553.8 % -213.4 % 0.11 3 0.0 % 0.0 % -56.3 58.2 % 11.1 % 4.7 (3)
ATLN Atlantic International Corp. 08/12 -33 % ⚠ Wildest 10% 201 % Stage 4 C 46 4 of 9 0.1 $ Staffing & Employment Services Industrials 0.75 $ +0.0 % -70.5 % -55.2 % −80.2 % +700.0 % 3 42 32.0 % 19.8 % -2.95 0.0 0.1 -1.1 9.6 % -13.6 % -390.0 % -6.4 % -1.5 % 2 0.0 % 0.0 % -1.0 3.4 % 2.6 %
CELU Celularity Inc -32 % ⚠ Wildest 10% 124 % Stage 4 D 28 3 of 9 0.0 $ Biotechnology Healthcare 1.30 $ -37.0 % -54.1 % -40.9 % −84.7 % +92.3 % 3 11 13.4 % 11.3 % 0.80 0.0 2.0 -36.8 24.4 % 0.0 % -6,367.2 % -30.9 % -51.0 % 3 0.0 % 0.0 % -35.6 12.8 % 28.5 % 4.0 (1)
LHAI Linkhome Holdings Inc. 08/11 ⚠ Wildest 10% 203 % Stage 4 D 33 2 of 9 0.0 $ Real Estate Services Real Estate 1.20 $ -90.4 % -90.5 % -86.1 % −97.1 % 3 8 11.9 % 11.3 % 0.0 0.9 2.7 56.8 3.6 % -1.4 % -2.8 % -5.0 % 0.05 +175.7 % 6 0.0 % 0.0 % 18.5 0.3 % 4.3 %
NHTC Natural Health Trend 07/29 -17 % 77 % Stage 4 E 19 2 of 9 0.0 $ Internet Retail Consumer Cyclical 1.50 $ -43.0 % -41.4 % -63.5 % −66.7 % 3 3 9.0 % 6.7 % 0.89 13.4 0.2 0.8 13.45 13.8 74.1 % -4.5 % -4.9 % -3.8 % 0.18 -7.4 % 5 26.7 % 2,666.7 % 3.0 12.7 % 0.5 %
VEEA Veea Inc. 08/18 ⚠ Wildest 10% 157 % Stage 4 D 36 4 of 9 0.3 $ Information Technology Services Technology 5.30 $ -48.2 % -60.7 % -50.3 % −84.5 % 3 42 16.5 % 14.0 % 0.29 0.0 616.0 164.5 74.3 % 0.0 % 0.0 % -40.6 % +56.6 % 1 0.0 % 0.0 % -25.4 3.2 % 35.7 %
LENZ LENZ Therapeutics Inc 07/29 -23 % 85 % Stage 4 D 29 1 of 9 0.1 $ Biotechnology Neutral Healthcare 4.10 $ -90.2 % −53.7 % +485.4 % 2 42 7.3 % 6.9 % 1.63 0.0 6.3 0.6 -8.0 -622.9 % 91.7 % 0.0 % -59.2 % -37.4 % 0.00 93.0 % 2 0.0 % 0.0 % 3.5 111.8 % 56.9 % 4.6 (8)
HRTX Heron Therapeuti 08/14 -22 % ⚠ Wildest 10% 97 % Stage 4 D 31 3 of 9 0.1 $ Biotechnology Healthcare 0.3157 $ -67.8 % -66.0 % -73.9 % −82.2 % +2,102.6 % 2 42 7.0 % 8.8 % 1.62 46.9 0.4 49.7 61.9 % -22.5 % -2,408.9 % -2.8 % +7.4 % 2 0.0 % 0.0 % -19.6 83.3 % 30.1 % 4.7 (3)
CDLX Cardlytics Inc 08/05 -32 % ⚠ Wildest 10% 100 % Stage 4 D 34 3 of 9 0.0 $ Advertising Agencies Communication Services 3.90 $ -53.6 % -60.1 % -72.8 % −22.3 % +53.8 % 2 13 7.3 % 9.4 % 0.69 36.5 0.1 1.7 -7.7 48.9 % -52.8 % -356.0 % -7.4 % -52.47 -16.2 % 3 0.0 % 0.0 % -14.8 29.9 % 11.2 % 2.8 (6)
GAMB Gambling.com Group Ltd 08/13 -26 % ⚠ Wildest 10% 352 % Stage 4 D 35 4 of 9 0.1 $ Gambling Consumer Cyclical 1.90 $ -59.2 % -59.4 % -95.2 % −82.3 % +163.2 % 2 80 4.8 % 6.6 % 0.73 17.7 0.4 0.6 27.2 11.0 88.4 % -27.4 % -35.6 % 6.0 % 1.13 +30.1 % 4 0.0 % 0.0 % 3.6 40.2 % 4.5 % 5.0 (7)
TVRD Tvardi Therapeutics, Inc. 08/13 -33 % ⚠ Wildest 10% 213 % Stage 4 E 23 3 of 9 0.0 $ Biotechnology Healthcare 1.60 $ -43.7 % -52.5 % -95.9 % −94.6 % +458.8 % 2 42 15.3 % 10.3 % 0.0 1.0 0.0 0.0 % -237.8 % -55.5 % 0.01 -100.0 % 4 0.0 % 0.0 % -8.9 28.9 % 2.0 % 5.0 (4)
CRMT Americas Car-Mart Inc 07/02 -32 % ⚠ Wildest 10% 158 % Stage 4 D 32 2 of 9 0.0 $ Auto & Truck Dealerships Neutral Consumer Cyclical 1.80 $ -84.7 % -90.3 % -94.5 % −94.0 % +316.7 % 1 98 27.8 % 22.0 % 1.27 28.3 0.0 0.0 0.1 0.69 41.0 12.3 % -18.7 % -18.2 % -3.4 % 1.99 -0.2 % 3 0.0 % 0.0 % 9.2 87.7 % 24.5 % 3.3 (4)
KITT Nauticus Robotics Inc. 08/11 -33 % ⚠ Wildest 10% 150 % Stage 4 D 31 4 of 9 0.0 $ Aerospace & Defense Industrials 0.6233 $ -79.3 % -83.1 % -97.6 % −77.6 % +297.0 % 1 42 11.5 % 10.3 % -0.21 0.0 1.4 1.1 -3.7 -205.3 % 0.0 % -1,474.4 % -37.1 % 5.75 +191.8 % 1 0.0 % 0.0 % -31.5 3.6 % 13.1 % 5.0 (1)
MDXH MDxHealth SA 08/13 -33 % ⚠ Wildest 10% 112 % Stage 4 C 47 4 of 9 0.0 $ Diagnostics & Research Healthcare 0.6717 $ -85.6 % -88.5 % -81.8 % −91.5 % +164.4 % 1 42 9.1 % 10.9 % -501,643.70 27.7 0.2 36.6 17.6 62.9 % -32.7 % -2,440.4 % -9.8 % -7.86 +19.8 % 4 0.0 % 0.0 % -6.8 48.5 % 1.9 % 4.8 (6)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Weak 3-month RS (≤ 10) and falling today — negative momentum.

All scanners are recalculated daily across the entire stock universe — most recently on September 18, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 53 stocks pass this scanner's criteria (as of September 18, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.

This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?